FDA Inspection 1301396 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on March 25, 2026 in Topeka, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 25, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Topeka, KS (United States)